SIGMA STABILISED POOL CHLORINE TABLETS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sigma stabilised pool chlorine tablets

sigma chemicals (1986) pty. ltd. - chlorine present as trichloroisocyanuric acid - pool chlorine - swimming pool - outdoor - algae | bacteria

Sigmacort Ointment 1% Australia - English - Department of Health (Therapeutic Goods Administration)

sigmacort ointment 1%

aspen pharmacare australia pty ltd - hydrocortisone acetate, quantity: 10 mg/g - ointment - excipient ingredients: hard paraffin; liquid paraffin; wool fat; white soft paraffin - topical corticosteroid therapy for non-infective inflammatory conditions of the skin eg. eczema, dermatitis.

Sigmacort Cream 1% Australia - English - Department of Health (Therapeutic Goods Administration)

sigmacort cream 1%

aspen pharmacare australia pty ltd - hydrocortisone acetate, quantity: 10 mg/g - cream - excipient ingredients: liquid paraffin; purified water; chlorocresol; cetostearyl alcohol; cetomacrogol 1000; white soft paraffin - topical corticosteroid therapy for non-infective inflammatory conditions of the skin eg. eczema, dermatitis.

SIGMA LIQUID CHLORINE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sigma liquid chlorine

cromag pty ltd - chlorine present as sodium hypochlorite - liquid - chlorine present as sodium hypochlorite mineral-chlorine active 125.0 g/l - pool chlorine - spa | swimming pool | outdoor spa | spa pools - algae | bacteria

RISPERIDONE- risperidone solution United States - English - NLM (National Library of Medicine)

risperidone- risperidone solution

breckenridge pharmaceutical, inc. - risperidone (unii: l6uh7zf8hc) (risperidone - unii:l6uh7zf8hc) - risperidone 1 mg in 1 ml - risperidone oral solution is indicated for the treatment of schizophrenia. efficacy was established in 4 short-term trials in adults, 2 short-term trials in adolescents (ages 13 to 17 years), and one long-term maintenance trial in adults [see clinical studies (14.1) ]. monotherapy risperidone oral solution is indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder. efficacy was established in 2 short-term trials in adults and one short-term trial in children and adolescents (ages 10 to 17 years) [see clinical studies (14.2) ]. adjunctive therapy risperidone oral solution adjunctive therapy with lithium or valproate is indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder. efficacy was established in one short-term trial in adults [see clinical studies (14.3) ]. risperidone oral solution is indicated for the treatment of irritability associated with autistic disorder, including symptoms of aggression towards others, deliberate se

RISPERIDONE- risperidone solution United States - English - NLM (National Library of Medicine)

risperidone- risperidone solution

heritage pharmaceuticals inc. - risperidone (unii: l6uh7zf8hc) (risperidone - unii:l6uh7zf8hc) - risperidone 1 mg in 1 ml - risperidone is indicated for the treatment of schizophrenia. efficacy was established in 4 short-term trials in adults, 2 short-term trials in adolescents (ages 13 to 17 years), and one long-term maintenance trial in adults [see clinical studies (14.1) ]. monotherapy risperidone is indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder. efficacy was established in 2 short-term trials in adults and one short-term trial in children and adolescents (ages 10 to 17 years) [see clinical studies (14.2) ]. adjunctive therapy risperidone adjunctive therapy with lithium or valproate is indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder. efficacy was established in one short-term trial in adults [see clinical studies (14.3) ]. risperidone is indicated for the treatment of irritability associated with autistic disorder, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing

Cocois ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cocois ointment

sigma pharmaceuticals plc - sulfur precipitated; coal tar solution; salicylic acid - cutaneous ointment - 40mg/1gram ; 120mg/1gram ; 20mg/1gram

Calamine lotion United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

calamine lotion

sigma pharmaceuticals plc - calamine; zinc oxide; glycerol; bentonite; sodium citrate; phenol liquefied - cutaneous liquid - 150mg/1ml ; 50mg/1ml ; 50mg/1ml ; 30mg/1ml ; 5mg/1ml ; 5mg/1ml